Name (Synonyms) | Correlation | |
---|---|---|
drug107 | ATAFENOVIR 200 MG KAPSUL Wiki | 1.00 |
drug2507 | SBI-101 Wiki | 1.00 |
There is one clinical trial.
A single dose of Reference product containing 200 mg umifenovir hydrochloride monohydrate equivalent to 200 mg umifenovir hydrochloride and a single dose of Test product containing 200 mg umifenovir hydrochloride monohydrate equivalent to 200 mg umifenovir hydrochloride or vice versa; administered with 240 mL of water at room temperature, in each period under fasting conditions with Covid-19 Pandemic precautions.
Description: AUC0-tlast umifenovir
Measure: Primary PK Endpoint Time: 12 weeksDescription: Cmax of umifenovir
Measure: Primary PK Endpoint Time: 13 weeksDescription: t1/2 of umifenovir
Measure: Secondary PK Endpoint Time: 14 weeksDescription: tmax of umifenovir
Measure: Secondary PK Endpoint Time: 15 weeksDescription: AUC0-inf of umifenovir
Measure: Secondary PK Endpoint Time: 16 weeks